Astrocyte targeted overexpression of TGFβ1 resulted in earlier and more severe experimental autoimmune encephalomyelitis [52, 84], while systemic administration inhibited disease [43]. The gene discussed is TGFB1; the disease is experimental autoimmune encephalomyelitis.